Published in Physiol Behav on January 01, 1988
Insulin regulates brain function, but how does it get there? Diabetes (2014) 1.56
Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci (2006) 1.27
Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology (2008) 1.05
Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier. Endocrinology (2008) 1.01
Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol (Lausanne) (2014) 0.98
Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward. Nat Commun (2015) 0.94
Insulin increases central apolipoprotein E levels as revealed by an improved technique for collection of cerebrospinal fluid from rats. J Neurosci Methods (2012) 0.84
A physiological increase of insulin in the olfactory bulb decreases detection of a learned aversive odor and abolishes food odor-induced sniffing behavior in rats. PLoS One (2012) 0.83
Modulation of olfactory sensitivity and glucose-sensing by the feeding state in obese Zucker rats. Front Behav Neurosci (2014) 0.78
Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia. Med Hypotheses (2015) 0.77
Estrogen and insulin transport through the blood-brain barrier. Physiol Behav (2016) 0.76
Central nervous system control of food intake. Nature (2000) 15.85
The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest (1966) 4.92
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature (1979) 4.08
A receptor mechanism for the inhibition of insulin release by epinephrine in man. J Clin Invest (1967) 3.48
Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med (1996) 3.20
The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest (1967) 2.87
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest (1984) 2.85
Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes (1996) 2.83
Signals that regulate food intake and energy homeostasis. Science (1998) 2.70
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 2.61
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes (1997) 2.32
A new LexA-based genetic system for monitoring and analyzing protein heterodimerization in Escherichia coli. Mol Gen Genet (1998) 2.25
Neural control of the endocrine pancreas. Physiol Rev (1974) 2.21
Beta adrenergic stimulation of insulin release in man. Diabetes (1967) 2.14
Insulin secretion in diabetes mellitus. Am J Med (1981) 2.05
Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev (1992) 2.03
Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes (1990) 2.00
Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med (1967) 1.87
Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med (1968) 1.85
Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus. Arch Intern Med (1969) 1.81
Inhibition of insulin release by norepinephrine in man. Science (1966) 1.78
Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes (1982) 1.69
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol (2000) 1.66
Insulin responses to glucose: evidence for a two pool system in man. J Clin Invest (1969) 1.66
Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology (1992) 1.65
Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res (1999) 1.64
Obesity, diabetes and the central nervous system. Diabetologia (1998) 1.62
The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes. Diabetes (1982) 1.59
Human insulin secretion: as integrated approach. Annu Rev Med (1970) 1.55
The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest (1973) 1.53
AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem (2001) 1.51
Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia (1986) 1.49
Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes (2000) 1.48
Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate. J Clin Endocrinol Metab (1971) 1.48
Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care (1984) 1.48
Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr (2001) 1.45
Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab (1985) 1.43
Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man. Metabolism (1966) 1.41
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest (1973) 1.38
Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1998) 1.38
The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci (2000) 1.38
Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav (2000) 1.36
Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest (1973) 1.35
Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia (1987) 1.34
Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol (1984) 1.33
Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology (1990) 1.32
Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol (1990) 1.31
Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem (1978) 1.30
Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol (1997) 1.30
The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes (1986) 1.30
Adrenergic modulation of basal insulin secretion in man. Diabetes (1973) 1.29
Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol (1984) 1.29
Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes (1996) 1.29
Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection. Am J Physiol Regul Integr Comp Physiol (2001) 1.29
The effect of vertical sleeve gastrectomy on food choice in rats. Int J Obes (Lond) (2012) 1.28
Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc (1973) 1.28
Neural regulation of insulin secretion in the dog. J Clin Invest (1973) 1.28
Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes (1974) 1.27
Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem (1999) 1.26
Glucose disposal is not proportional to plasma glucose level in man. Diabetes (1981) 1.26
Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr (1985) 1.25
Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N Engl J Med (1971) 1.25
Insulin in the brain. Annu Rev Physiol (1987) 1.23
Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res (1996) 1.23
Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. J Clin Invest (1972) 1.22
Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab (1987) 1.22
Mechanism of plasma catecholamine increases during surgical stress in man. J Clin Endocrinol Metab (1977) 1.20
Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes (1985) 1.19
A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest (1976) 1.19
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes (1988) 1.18
Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man. Diabetes (1978) 1.17
Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. J Clin Endocrinol Metab (1979) 1.15
Hypothalamic response to starvation: implications for the study of wasting disorders. Am J Physiol (1995) 1.14
Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol (2000) 1.14
Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia). J Clin Invest (1970) 1.13
Cardiovascular and metabolic responses to exercise in a patient with McArdle's syndrome. N Engl J Med (1966) 1.13
Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest (1991) 1.12
Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res (1994) 1.12
Role of the CNS melanocortin system in the response to overfeeding. J Neurosci (1999) 1.12
Biological consequences of drug administration: implications for acute and chronic tolerance. Psychol Rev (1997) 1.11
Quantitative evaluation of sympathetic and parasympathetic control of iris function. Diabetes Care (1984) 1.11
Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol (1977) 1.10
Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci (1995) 1.10
Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1990) 1.09
Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes (1989) 1.09
The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev (1996) 1.09